EVYD Technology optimises healthcare outcomes through data intelligence

With Covid-19 impacting communities in many ways, researchers and healthcare providers have increasingly turned to big data analytics and artificial intelligence (AI) tools to track and monitor the virus’s spread and its effect on humanity and the global economy.

The enormous amount of data the pandemic has generated has given researchers the opportunity to analyse trends, monitor patient populations, and begin to rectify long standing issues in the healthcare industry. Additionally, healthcare organisations and practitioners are increasingly turning to predictive models to better understand which patients are at risk, where resources are most needed, and where the disease is likely to spike next.

In an insightful conversation with Ming Jie Chua, CEO of EVYD Technology, we discover how healthcare organisations can unlock the potential of data to drive better outcomes for public health, including the pivotal role of collaboration in driving impactful, sustainable change in healthcare.

EVYD Technology is a healthcare AI and big data company with a mission to transform healthcare using data intelligence. Headquartered in Brunei and Singapore with operations in the Middle East, Southeast Asia and the United States, the startup was set up as an independent entity by Yidu Tech Inc. in April 2020 to serve the global healthcare market.

During the conversation, Ming Jie also speak about:

The genesis of EVYD and its relationship with Yidu Tech.
How the company works in tandem with governments to curb the spread of Covid-19.
The importance of data sharing and digitalisation to empower scientific policy making in healthcare.
How big data and artificial intelligence provide sharper insights and better outcomes for public health.
EVYD’s three solutions suites and its benefits to its users.
The company’s accelerated scale over the last two years and its biggest catalyst for growth.
Future plans.